Dr. Lal Path Labs P/E Ratio
Dr. Lal Path Labs P/E ratio. Dr. Lal Path Labs (LALPATHLAB) P/E ratio is 57.12 (High), EPS (TTM) ₹30.24, current price ₹1843.70 on NSE vs historical average P/E of 56.4 (90.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see LALPATHLAB share price screener.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
LALPATHLAB P/E Ratio — Valuation Signal & Historical Context
Dr. Lal Path Labs P/E 57.12 vs historical average 56.4, range 31.68–131.38 — signal: Overvalued. Examine Dr. Lal Path Labs quarterly earnings for recent quarterly revenue, profit and EPS trends.
- Stock appears overvalued with PE of 57.12, suggesting caution for new investments
- Trading at discount to sector average PE of 90.26
Dr. Lal Path Labs P/E Ratio Historical Trend
LALPATHLAB annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 57.12 vs historical average 56.4. Also explore LALPATHLAB price movement history to track price trends across different timeframes.
LALPATHLAB Historical P/E Ratio — EPS, Year-End Price & Valuation
Dr. Lal Path Labs annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2025 | 52.71 | 57.92 | ₹3053.05 | NSE | High |
| 2024 | 51.47 | 50.04 | ₹2575.35 | NSE | High |
| 2023 | 55.39 | 39.72 | ₹2200.15 | NSE | High |
| 2022 | 131.38 | 29.39 | ₹3861.30 | NSE | High |
| 2021 | 54.23 | 44.39 | ₹2407.20 | NSE | High |
| 2020 | 52.57 | 29.17 | ₹1533.40 | NSE | High |
| 2019 | 31.68 | 29.19 | ₹924.80 | NSE | High |
| 2018 | 37.87 | 23.36 | ₹884.65 | NSE | High |
| 2017 | 55.04 | 19.78 | ₹1088.65 | NSE | High |
| 2016 | 41.64 | 19.3 | ₹803.60 | NSE | High |
LALPATHLAB vs Healthcare Services Peers — P/E Ratio Comparison
Dr. Lal Path Labs P/E 57.12 vs Healthcare Services average 90.26, median 41.67 — range 6.49–1628.57.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 6.49 | ₹128 | Low |
| Abate AS Industries | ABATEAS | 9.74 | ₹115 | Low |
| Nidan Labs & Healthcare | NIDAN | 11.94 | ₹18 | Low |
| Deccan Health Care | DECCAN | 12.54 | ₹32 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.49 | ₹1,074 | Low |
| Shanmuga Hospital | SHANMUGA | 14.58 | ₹59 | Low |
| Indraprastha Medical Cor… | INDRAMEDCO | 15.61 | ₹2,891 | Moderate |
| Clinitech Laboratory | CTLLAB | 17.58 | ₹7 | Moderate |
| Krsnaa Diagnostics | KRSNAA | 17.75 | ₹1,663 | Moderate |
| Invicta Diagnostic | INVICTA | 17.78 | ₹79 | Moderate |